LUMOS PHARMA, INC. Insider Trading for January 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LUMOS PHARMA, INC. for January 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Option Exercise | A | 34.73 | 46,351 | 1,609,770 | 46,351 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Sell | S | 35.74 | 175 | 6,255 | 62,316 | 62.5 K to 62.3 K (-0.28 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | HENNEMAN JOHN B III | EVP, Chief Financia ... | Grant | A | 0.00 | 16,201 | 0 | 62,491 | 46.3 K to 62.5 K (+35.00 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Option Exercise | A | 34.73 | 8,989 | 312,188 | 8,989 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Sell | S | 35.42 | 500 | 17,710 | 13,465 | 14 K to 13.5 K (-3.58 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Sell | S | 34.60 | 595 | 20,587 | 13,965 | 14.6 K to 14 K (-4.09 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Principal Accountin ... | Grant | A | 0.00 | 3,142 | 0 | 14,560 | 11.4 K to 14.6 K (+27.52 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Option Exercise | A | 34.73 | 18,259 | 634,135 | 18,259 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 35.20 | 1,000 | 35,200 | 19,942 | 20.9 K to 19.9 K (-4.78 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Sell | S | 34.26 | 295 | 10,107 | 20,942 | 21.2 K to 20.9 K (-1.39 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Wiley Brian | VP of Business Deve ... | Grant | A | 0.00 | 6,382 | 0 | 21,237 | 14.9 K to 21.2 K (+42.96 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Option Exercise | A | 34.73 | 133,435 | 4,634,198 | 133,435 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 33.06 | 7,900 | 261,174 | 342,756 | 350.7 K to 342.8 K (-2.25 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 32.29 | 17,100 | 552,159 | 350,656 | 367.8 K to 350.7 K (-4.65 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 35.29 | 3,621 | 127,785 | 367,756 | 371.4 K to 367.8 K (-0.98 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Sell | S | 34.46 | 1,380 | 47,555 | 371,377 | 372.8 K to 371.4 K (-0.37 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Link Charles J. Jr. | Chairman of the Boa ... | Grant | A | 0.00 | 46,639 | 0 | 372,757 | 326.1 K to 372.8 K (+14.30 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Option Exercise | A | 34.73 | 84,275 | 2,926,871 | 84,275 | |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 35.57 | 1,000 | 35,570 | 65,284 | 66.3 K to 65.3 K (-1.51 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Sell | S | 34.80 | 2,011 | 69,983 | 66,284 | 68.3 K to 66.3 K (-2.94 %) |
| Jan 06 2016 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President, Chief Me ... | Grant | A | 0.00 | 29,456 | 0 | 68,295 | 38.8 K to 68.3 K (+75.84 %) |